N/ARecruiting
Alleviant ALLAY-HFrEF Study
Sponsored by Alleviant Medical, Inc.
About this study
Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.
Enrolling at this location
Midwest Cardiovascular Institute
Naperville, Illinois
I'm interestedThis study also enrolls at 39 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.